Advanced search
Publication Cover
European Journal of General Practice Volume 29, 2023 - Issue 2: Special Issue on COVID-19
Submit an article Journal homepage
1,161
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign

Eline Meyersa Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, BelgiumORCID Iconhttps://orcid.org/0000-0002-3549-9548View further author information
ORCID Icon,
Liselore De Ropb Department of Public Health and Primary Care, EPI-Centre, ACHG, Leuven, BelgiumORCID Iconhttps://orcid.org/0000-0003-0111-9508View further author information
ORCID Icon,
Ellen Deschepperc Faculty of Medicine and Health Sciences, Biostatistics Unit, Ghent University, Ghent, BelgiumView further author information
,
Els Duysburghd Department of Epidemiology and Public Health, Sciensano, Brussels, BelgiumORCID Iconhttps://orcid.org/0000-0003-3345-7616View further author information
ORCID Icon,
Tine De Burghgraeveb Department of Public Health and Primary Care, EPI-Centre, ACHG, Leuven, BelgiumORCID Iconhttps://orcid.org/0000-0002-0561-6504View further author information
ORCID Icon,
Pauline Van Ngoce Department of General Medicine, Faculty of Medicine, Research Unit of Primary Care and Health, University of Liège, Liège, BelgiumORCID Iconhttps://orcid.org/0000-0003-0925-9994View further author information
ORCID Icon,
Marina Digregorioe Department of General Medicine, Faculty of Medicine, Research Unit of Primary Care and Health, University of Liège, Liège, BelgiumORCID Iconhttps://orcid.org/0000-0002-5317-7788View further author information
ORCID Icon,
Simon Delognee Department of General Medicine, Faculty of Medicine, Research Unit of Primary Care and Health, University of Liège, Liège, BelgiumView further author information
,
Anja Coenf Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, BelgiumView further author information
,
Nele De Clercqf Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, BelgiumView further author information
,
Laëtitia Burete Department of General Medicine, Faculty of Medicine, Research Unit of Primary Care and Health, University of Liège, Liège, BelgiumORCID Iconhttps://orcid.org/0000-0002-5653-615XView further author information
ORCID Icon,
Samuel Coeneng Department of Family Medicine and Population Health (FAMPOP) and Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, BelgiumORCID Iconhttps://orcid.org/0000-0002-1238-8052View further author information
ORCID Icon,
An De Sutterf Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, BelgiumORCID Iconhttps://orcid.org/0000-0002-2540-8307View further author information
ORCID Icon,
Beatrice Scholtese Department of General Medicine, Faculty of Medicine, Research Unit of Primary Care and Health, University of Liège, Liège, BelgiumORCID Iconhttps://orcid.org/0000-0001-5274-822XView further author information
ORCID Icon,
Jan Y. Verbakelb Department of Public Health and Primary Care, EPI-Centre, ACHG, Leuven, Belgium;h Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UKORCID Iconhttps://orcid.org/0000-0002-7166-7211View further author information
ORCID Icon,
Piet Coolsa Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, BelgiumORCID Iconhttps://orcid.org/0000-0003-2980-5307View further author information
ORCID Icon &
Stefan Heytensf Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, BelgiumCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1097-4987View further author information
ORCID Icon show all
Article: 2149732 | Received 10 Aug 2022, Accepted 03 Nov 2022, Published online: 28 Nov 2022

References

  • Peeters I, Vermeulen M, Bustos Sierra N, et al. Surveillance van COVID-19 gerelateerde mortaliteit in België, epidemiologie en methodologie tijdens 1e en 2e golf (maart 2020 - 14 februari 2021) [Surveillance of COVID-19 mortality in Belgium during the 1st and 2nd wave (March 2020 - 14 February 2021)]. Brussels: Sciensano; 2021.
  • Catteau L, Haarhuis F, Dequeker S, et al. Surveillance of COVID-19 vaccinations in Belgian nursing homes 2021. Brussels: Sciensano; 2021.
  • Walsh EE, Frenck RW, Falsey AR, et al. Safety and immunogenicity of two RNA-based covid-19 vaccine candidates. N Engl J Med. 2020;383(25):2439–2450.
  • Mulligan MJ, Lyke KE, Kitchin N, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586(7830):589–593.
  • Bewoner woonzorgcentrum gemiddeld 87 jaar [Nursing home resident is on average 87 years old] [Internet]. 2020. [cited 2022 November 10]. Available from: https://www.vlaanderen.be/statistiek-vlaanderen/zorg/zorg-en-ondersteuning-voor-ouderen
  • Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615.
  • Fulop T, Pawelec G, Castle S, et al. Immunosenescence and vaccination in nursing home residents. Clin Infect Dis. 2009;48(4):443–448.
  • Dequeker S, Callies M, Latour K, et al. COVID-19 surveillance in woonzorgcentra (rapport week 31) [COVID-19 surveillance in nursing homes (report week 31)]. Brussels: Sciensano; 2021. p. 399.
  • Triest D, Geebelen L, De Pauw R, et al. Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2. J Clin Virol. 2021;142:104897.
  • Wallace M, Shelkey M, Hartford Institute for Geriatric Nursing. Katz index of independence in activities of daily living (ADL). Urol Nurs. 2007;27(1):93–94.
  • Specific recommendations for persons at increased risk for a serious course of COVID-19: sciensano. 2021. Brussels: Sciensano. [cited 2022 November 10]. Available from: https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_measures-for-high-risk-groups_NL.pdf
  • Belgium COVID-19 epidemiological situation - seroprevalence studies [Internet]. Brussels: Sciensano; 2022. [cited 2022 November 10]. Available from: https://datastudio.google.com/embed/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB
  • Salmerón Ríos S, Mas Romero M, Cortés Zamora EB, et al. Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID-A study. J Am Geriatr Soc. 2021;69(6):1441–1447.
  • Canaday DH, Carias L, Oyebanji OA, et al. Reduced BNT162b2 messenger RNA vaccine response in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naive nursing home residents. Clin Infect Dis. 2021;73(11):2112–2115.
  • Pannus P, Neven KY, De Craeye S, et al. Poor antibody response to BioNTech/pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes. Clin Infect Dis. 2022;75(1):e695–e704.
  • Witkowski W, Gerlo S, De Smet E, et al. Humoral and cellular responses to COVID-19 vaccination indicate the need for Post-Vaccination testing in frail population. Vaccines. 2022;10(2):260.
  • Collier DA, Ferreira IATM, Kotagiri P, et al. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature. 2021 2021;596(7872):417–422.
  • Müller L, Andrée M, Moskorz W, et al. Age-dependent immune response to the biontech/pfizer BNT162b2 COVID-19 vaccination. Clin Infect Dis. 2021;73(11):2065–2072.
  • Bates TA, Leier HC, Lyski ZL, et al. Age-Dependent neutralization of SARS-CoV-2 and P.1 variant by vaccine immune serum samples. J Am Med Assoc. 2021;326(9):868–869.
  • Kwetkat A, Heppner HJ. Comorbidities in the elderly and their possible influence on vaccine response. Interdiscip Top Gerontol Geriatr. 2020;43:73–85.
  • Remarque EJ, de Bruijn IA, Boersma WJ, et al. Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay. J. Med. Virol. 1998;55(1):82–87.
  • Ridda I, MacIntyre CR, Lindley R, et al. Immunological responses to pneumococcal vaccine in frail older people. Vaccine. 2009;27(10):1628–1636.
  • Frasca D, Blomberg BB. Cell function and influenza vaccine responses in healthy aging and disease. Curr Opin Immunol. 2014;29:112–118.
  • Nath KD, Burel JG, Shankar V, et al. Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:51–56.
  • Janssens H, Heytens S, Meyers E, et al. Pre-vaccination SARS-CoV-2 seroprevalence among staff and residents of nursing homes in flanders (Belgium) in fall 2020. Epidemiol Infect. 2022;150:1–25.
  • Cascini F, Pantovic A, Al-Ajlouni Y, et al. Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: a systematic review. EClinicalMedicine. 2021;40:101113.
  • Digregorio M, Van Ngoc P, Delogne S, et al. Vaccine hesitancy towards the COVID-19 vaccine in a random national sample of Belgian nursing home staff members. Vaccines (Basel. 2022;10(4):598.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.